ABCA1 and Alzheimer disease: Bexarotene and LG100268 are RXR agonists that promote dimerization and activation of both LXRs and peroxisome proliferator-activated receptor-gamma (PPAR-γ), resulting in the increase of apoE lipidation and ABCA1 expression in AD animal models [115,116,117].